Assessing long-term effects of MDMA - Ecstasy

G. A. RICAURTE ; U. D. McCANN ; L. RENEMAN ; J. BOOIJ ; K. DE BRUIN ; J. B. REITSMA ; F. A. DE WOLFF ; W. BOUDEWIJN GUNNING ; G. J. DEN HEETEN ; W. VAN DEN BRINK | 2001
Périodique

ENGLISH : Background 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) is a popular recreational drug that has been shown to damage brain serotonin neurons in high doses. However, effects of moderate MDMA use on serotonin neurons have not be[...]

Plus d'info

Ajouter à la sélection

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I] b -CIT SPECT study - preliminary report

L. RENEMAN ; J. BOOIJ ; J. LAVALAYE ; K. DE BRUIN ; J. B. REITSMA ; W. BOUDEWIJN GUNNING ; G. J. DEN HEETEN ; W. VAN DEN BRINK | 2002
Dans Psychopharmacology (Vol.159, n°3, January 2002) Article : Périodique

RATIONALE. Tablets sold as ecstasy often contain not only 3,4-methylenedioxymethamphetamine (MDMA) but other compounds well known to cause doparninergic neurotoxicity, such as (meth)amphetamine. Furthermore, the use of ecstasy in the Netherlands[...]

Plus d'info

Ajouter à la sélection